Abstract ID | Abstract Title | Presenting Author Name |
Presentation Date |
Presentation Time |
55 | Outcomes of Autologous Stem-cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma – Is Less “Sufficient” and “Safe” in the MRD Era? | Sumeet Mirgh | 03-05-2025 | 09:00 AM - 09:10 AM |
60 | Comparison of conditioning regimens used for alternate donor hematopoietic stem cell transplantation in thalassemia - a single center experience from north India | Sohini Chakraborty | 03-05-2025 | 09:10 AM - 09:20 AM |
149 | Diagnostic Value, Predictive Significance and Kinetics of Faecal Calprotectin in Suspected Acute Gut GVHD / GVHD Flare Post Allogeneic Stem Cell Transplant | Rashmi Ranjan Pradhan | 03-05-2025 | 09:20 AM - 09:30 AM |
77 | The impact of neurological complications in children undergoing haematopoietic stem cell transplantation – a retrospective analysis over two decades | Krithika Krishnakumar | 03-05-2025 | 09:30 AM - 09:40 AM |
61 | A low cost preventive strategy for hepatic veno occlusive disease in class III thalassemia patients – a single center experience | Sohini Chakraborty | 03-05-2025 | 09:40 AM - 09:50 AM |
119 | Benchmarking stem cell transplant survival outcomes in benign and malignant hematologic disorders: A cross-registry analysis of a North Indian single center with CIBMTR and EBMT data. | Himanshu | 03-05-2025 | 09:50 AM - 10:00 AM |
50 | Twenty-two years follow up on the incidence of malignancies in children post Hematopoietic Stem Cell Transplantation | Vijayshree Muthukumar | 04-05-2025 | 08:00 AM - 08:10 AM |
34 | Excellent thalassaemia free survival in haploidentical hematopoietic stem cell transplantation with myeloablative conditioning and posttransplant cyclophosphamide in older children with antibodies and transfusion dependent thalassemia – a retrospective co | Kavitha Ganesan | 04-05-2025 | 08:10 AM - 08:20 AM |
140 | Pretransplant Host Status, Rather Than HLA Matching, Determines Hematopoietic stem cell transplant outcomes in Patients with Inborn Errors of Immunity | Mahafrin Homiar Goiporia | 04-05-2025 | 08:20 AM - 08:30 AM |
47 | A pilot study to find an optimized option for platelet transfusion in pediatric stem cell transplant recipients | Divya Setya | 04-05-2025 | 08:30 AM - 08:40 AM |
25 | Fixed-Dose Pegylated G-CSF and Plerixafor: Faster, Safer Stem Cell Mobilisation | Sai Kiran | 04-05-2025 | 08:40 AM - 08:50 AM |
62 | Real-world outcomes of adults with acute lymphoblastic leukaemia (ALL) undergoing allogeneic transplantation: Multi-center data from the Indian Society of Blood and Marrow Transplant (ISBMT) | Punit Jain | 04-05-2025 | 08:50 AM - 09:00 AM |